Xenetic Biosciences, Inc. (XBIO)
1.72
-0.21
(-10.88%)
USD |
NASDAQ |
Oct 23, 16:00
1.71
-0.01
(-0.58%)
After-Hours: 20:00
Xenetic Biosciences EPS Diluted (Quarterly) : -0.4052 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4052 |
| March 31, 2026 | -0.1992 |
| December 31, 2025 | -0.2528 |
| September 30, 2025 | -0.3307 |
| June 30, 2025 | -0.4466 |
| March 31, 2025 | -0.5856 |
| December 31, 2024 | -0.6838 |
| September 30, 2024 | -0.2832 |
| June 30, 2024 | -0.8268 |
| March 31, 2024 | -0.7757 |
| December 31, 2023 | -0.7622 |
| September 30, 2023 | -0.6887 |
| June 30, 2023 | -0.6893 |
| March 31, 2023 | -0.5648 |
| December 31, 2022 | -0.9775 |
| September 30, 2022 | -0.5616 |
| June 30, 2022 | -1.900 |
| March 31, 2022 | -1.186 |
| December 31, 2021 | -1.370 |
| September 30, 2021 | -1.329 |
| June 30, 2021 | -1.265 |
| March 31, 2021 | -1.539 |
| December 31, 2020 | -1.588 |
| September 30, 2020 | -12.01 |
| June 30, 2020 | -1.516 |
| Date | Value |
|---|---|
| March 31, 2020 | -1.892 |
| December 31, 2019 | -1.929 |
| September 30, 2019 | -26.68 |
| June 30, 2019 | -15.61 |
| March 31, 2019 | -64.54 |
| December 31, 2018 | -20.92 |
| September 30, 2018 | -23.13 |
| June 30, 2018 | -27.80 |
| March 31, 2018 | -25.09 |
| December 31, 2017 | 61.19 |
| September 30, 2017 | -31.05 |
| June 30, 2017 | -40.23 |
| March 31, 2017 | -40.37 |
| December 31, 2016 | -63.18 |
| September 30, 2016 | -33.60 |
| June 30, 2016 | -734.40 |
| March 31, 2016 | -79.20 |
| December 31, 2015 | -94.92 |
| September 30, 2015 | -158.40 |
| June 30, 2015 | -39.60 |
| March 31, 2015 | -79.20 |
| December 31, 2014 | -122.32 |
| September 30, 2014 | -79.20 |
| June 30, 2014 | -79.20 |
| March 31, 2014 | -118.80 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.9297M |
| Revenue (Quarterly) | 0.6606M |
| Total Expenses (Quarterly) | 1.590M |
| Enterprise Value | -2.442M |
| Profit Margin (Quarterly) | -140.7% |
| Earnings Yield | -69.06% |
| Normalized Earnings Yield | -69.06 |